The FDA has delayed a decision on the approval of AstraZeneca’s camizestrant, deferring its ruling to review analyses filed ...
AstraZeneca and Daiichi Sankyo have secured approval from the US Food and Drug Administration (FDA) for Datroway (datopotamab ...
AbbVie’s ADC has secured FDA clearance for an ultra-rare blood cancer while the agency has delayed its decision on ...
US FDA extends PDUFA date and seeks additional data from AstraZeneca’s NDA for camizestrant in combo with a CDK 4/6 inhibitor to treat HR-positive, HER2-negative advanced breast ...
AstraZeneca has fired another volley in its bladder cancer competition with Merck’s Keytruda, with the FDA on Thursday ...
AstraZeneca was taken to task last week by the US Food and Drug Administration's (FDA's) Oncology Drug Advisory Committee (ODAC) for failing to heed an agency request about the design of a durvalumab ...
Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news like ...
Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and Amgen’s Tezspire demonstrated a statistically significant and ...
CHICAGO, Dec 7 (Reuters) - A top U.S. scientist overseeing COVID-19 vaccine trials expects a large U.S. study to determine how effective AstraZeneca's experimental inoculation is, following perplexing ...
NATIONAL — [March 31, 2026] — The Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards), an initiative dedicated to improving participation in and access to clinical trials, is ...